October 31, 2022
A key health ministry panel on October 28 determined that the new pediatric indication for Pfizer’s α2 agonist sedative Precedex (dexmedetomidine) should be subject to further deliberation before endorsing it for approval. The medicine had been awarded Japan’s first “drug...read more